(firstQuint)Clinical Study of FRC Implant to Treat Skull Bone Defects.

 Development phase: Clinical trial Objectives: Assessment of functional and aesthetic outcome Methodology: Intervention study Sample size: 35+20+25 Main criteria for inclusion: Skull bone defect OR orbital floor fracture Investigational drug/treatment, dose and mode of administration: FRC implant Comparative drug(s)/placebo/treatment, dose and mode of administration: - Duration of treatment: 2 years of follow-up Assessments: Clinical outcome and radiologic assesment Functional and aesthetic outcome with Visual Analog Scale (VAS).

 Pain assessment with VAS.

 Statistical methods: Adequate statistical methods for publishing in international peer-reviewed journals.

.

 Clinical Study of FRC Implant to Treat Skull Bone Defects@highlight

Bioactive fibre-reinforced composite implant is used for reconstruction of skull bone defects and orbital floor defects.

 Functional and aesthetic outcome is assessed by patient and doctor.

